Direxion Daily SandP Biotech Bear 3X ETF (LABD) |
| 8.05 0.54 (7.19%) 07-13 16:00 |
| Open: | 7.625 |
| High: | 8.05 |
| Low: | 7.625 |
| Volume: | 20,488,992 |
| Market Cap: | 18(M) |
| PE Ratio: | 0 |
| Exchange: | New York Stock Exchange Arca |
| Industry: | Asset Management - Leveraged |
| Sector: | Financial Services |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 15.23 |
| Resistance 1: | 11.97 |
| Pivot price: | 8.01 |
| Support 1: | 6.68 |
| Support 2: | 5.56 |
| 52w High: | 69.69 |
| 52w Low: | 6.68 |
The Direxion Daily S&P Biotech Bull and Bear 3X ETFs are designed to deliver daily investment returns reflecting triple (300%) the performance of the S&P Biotechnology Select Industry Index, or triple its inverse (opposite) performance, before factoring in any fees or expenses. It's important to note, however, that there is no assurance these funds will successfully achieve their intended daily objectives.
Financials
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Company news
Mon, 02 Feb 2026
LABD: ETF To Benefit From Downturns In The Biotech Industry (NYSEARCA:LABD) - Seeking Alpha
Wed, 01 Oct 2025
TBXU Stock Fund Price and Chart — AMEX:TBXU - TradingView
Thu, 10 Apr 2025
Top Performing Leveraged/Inverse ETFs: 04/06/2025 - ETF Database
Tue, 19 Nov 2024
Top Performing Leveraged/Inverse ETFs: 11/17/2024 - ETF Trends
Tue, 23 Apr 2024
Top Performing Leveraged/Inverse ETFs: 04/21/2024 - ETF Trends
Fri, 13 Dec 2019
Consider These 2 Leveraged Biotech ETFs to Ride The M&A Trend - ETF Trends
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
